Clinical Trials & Noteworthy Treatments For Brain Tumors

Brain Tumor Treatments: Delaware

http://virtualtrials.com/de.cfm

Copyright 2004 The Musella Foundation For Brain Tumor Research & Information, Inc.
The materials provided at this site are for informational purposes and are not intended for use as diagnosis
or treatment of a health problem or as a substitute for consulting a licensed medical professional.



Search Term: Delaware
Please scroll down to see the matching trials.

  (0.8351)   Brain Tumor Treatments: Delaware
  (0.7742)   Brain Tumor Activism
  (0.7742)   Letter Writing Wizard
  (0.7742)   Brain Tumor Activism
  (0.7742)   High Dose Tamoxifen For Brain Tumors
  (0.7742)   Untitled Document

Sorry - There were no pages found that contain that search phrase.



  Showing Treatment 1 to 8 of 8 Location Last Updated
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Newark, DE USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Lewes, DE USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Newark, DE USA 04/11/2008
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas Lewes, DE USA 05/01/2007
Details Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Newark, DE USA 05/01/2007
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Wilmington, DE USA 10/12/2006
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Wilmington, DE USA 11/27/2005
Details A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy Lewes, DE USA 11/06/2005